• Athene estimates $350 million in alternative net investment income for Q2 2026, reflecting a 9% annualized return.
• The announcement reflects Manulife’s focus on delivering reliable returns to its investor base.
• The transaction was funded with $10 million of 6% convertible notes convertible at $1.80 per Class B share.
• The officer’s final day of service is scheduled for August 1, 2026.
• Dr. Lam will keep his responsibilities as Chief Technology Officer overseeing AI, robotics and automation initiatives.
• Mobility Global (NYSE: MBGL) began trading as an independent company on July 1, 2026, following a 100% distribution of its shares to S&P Global stockholders.
• The offering was priced at $350M and specifically prices $350M 6.100% under the underwriting agreement.
• Hims & Hers Health (NYSE: HIMS) finalized a $400 million receivables purchase agreement with JPMorgan Chase Bank.
• Andy Reding’s base compensation is $500,000 per year, with a target bonus equal to 70% of that amount.
• The new facility allows for an additional borrowing capacity of up to $500 million for letters of credit.